Literature DB >> 25769518

Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.

N G R Dayan Elshan1, Thanuja Jayasundera2, Craig S Weber2, Ronald M Lynch3, Eugene A Mash4.   

Abstract

The synthesis, characterization, and use of Eu-DTPA-PEGO-Trp-Nle-Asp-Phe-NH2 (Eu-DTPA-PEGO-CCK4), a luminescent probe targeted to cholecystokinin 2 receptor (CCK2R, aka CCKBR), are described. The probe was prepared by solid phase synthesis. A Kd value of 17±2nM was determined by means of saturation binding assays using HEK-293 cells that overexpress CCK2R. The probe was then used in competitive binding assays against Ac-CCK4 and three new trivalent CCK4 compounds. Repeatable and reproducible binding assay results were obtained. Given its ease of synthesis, purification, receptor binding properties, and utility in competitive binding assays, Eu-DTPA-PEGO-CCK4 could become a standard tool for high-throughput screening of compounds in development targeted to cholecystokinin receptors.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholecystokinin 2 receptor; Dissociation-enhanced lanthanide fluoroimmunoassay; High-throughput screening; Multivalent binding; Time-resolved fluorescence

Mesh:

Substances:

Year:  2015        PMID: 25769518      PMCID: PMC4380538          DOI: 10.1016/j.bmc.2015.02.028

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

1.  Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.

Authors:  T M Behr; N Jenner; M Béhé; C Angerstein; S Gratz; F Raue; W Becker
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

2.  Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation.

Authors:  Séverine Brillouet; Sandra Dorbes; Frédéric Courbon; Claude Picard; Jean Pierre Delord; Eric Benoist; Marc Poirot; Béatrice Mestre-Voegtlé; Sandrine Silvente-Poirot
Journal:  Bioorg Med Chem       Date:  2010-05-19       Impact factor: 3.641

3.  Preparation and characterization of a probe for the cholecystokinin octapeptide receptor, N alpha (125I-desaminotyrosyl)CCK-8, and its interactions with pancreatic acini.

Authors:  L J Miller; S A Rosenzweig; J D Jamieson
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

Review 4.  Peptide-receptor ligands and multivalent approach.

Authors:  Paolo Ruzza; Anna Marchiani; Nicola Antolini; Andrea Calderan
Journal:  Anticancer Agents Med Chem       Date:  2012-06       Impact factor: 2.505

5.  Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors.

Authors:  Liping Xu; Josef Vagner; Ramesh Alleti; Venkataramanarao Rao; Bhumasamudram Jagadish; David L Morse; Victor J Hruby; Robert J Gillies; Eugene A Mash
Journal:  Bioorg Med Chem Lett       Date:  2010-03-04       Impact factor: 2.823

Review 6.  Lanthanide-based luminescent assays for ligand-receptor interactions.

Authors:  Heather L Handl; Robert J Gillies
Journal:  Life Sci       Date:  2005-02-19       Impact factor: 5.037

7.  Synthesis and evaluation of cholecystokinin trimers: a multivalent approach to pancreatic cancer detection and treatment.

Authors:  Nabila Brabez; Kevin L Nguyen; Kara Saunders; Ryan Lacy; Liping Xu; Robert J Gillies; Ronald M Lynch; Gerard Chassaing; Solange Lavielle; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

8.  Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.

Authors:  Ramesh Alleti; Josef Vagner; Dilani Chathurika Dehigaspitiya; Valerie E Moberg; N G R D Elshan; Narges K Tafreshi; Nabila Brabez; Craig S Weber; Ronald M Lynch; Victor J Hruby; Robert J Gillies; David L Morse; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2013-07-02       Impact factor: 3.641

9.  Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide.

Authors:  Jane K Sosabowski; Torkjel Matzow; Julie M Foster; Ciara Finucane; David Ellison; Susan A Watson; Stephen J Mather
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

Review 10.  Structural basis of cholecystokinin receptor binding and regulation.

Authors:  Laurence J Miller; Fan Gao
Journal:  Pharmacol Ther       Date:  2008-05-11       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.